1. Sekhon MS, Ainslie PN, Griesdale DE. Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a “two-hit” model. Crit Care. 2017; 21:90.
2. Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013; 369:2197–206.
3. Weerink MA, Barends CR, Muskiet ER, Reyntjens KM, Knotnerus FH, Oostra M, et al. Pharmacodynamic interaction of remifentanil and dexmedetomidine on depth of sedation and tolerance of laryngoscopy. Anesthesiology. 2019; 131:1004–17.
4. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992; 77:1134–42.
5. Makita K, Ishikawa S. Remifentanil. Masui. 2006; 55:817–25.
6. Feng G, Jiang G, Li Z, Wang X. Prognostic value of electroencephalography (EEG) for brain injury after cardiopulmonary resuscitation. Neurol Sci. 2016; 37:843–9.
7. Goodman PG, Mehta AR, Castresana MR. Predicting ischemic brain injury after intraoperative cardiac arrest during cardiac surgery using the BIS monitor. J Clin Anesth. 2009; 21:609–12.
8. Sandroni C, D’Arrigo S, Nolan JP. Prognostication after cardiac arrest. Crit Care. 2018; 22:150.
9. Endisch C, Storm C, Ploner CJ, Leithner C. Amplitudes of SSEP and outcome in cardiac arrest survivors: a prospective cohort study. Neurology. 2015; 85:1752–60.
10. Chen Z, Ding Y, Ji X, Meng R. Advances in normobaric hyperoxia brain protection in experimental stroke. Front Neurol. 2020; 11:50.
11. Walker AC, Johnson NJ. Targeted temperature management and postcardiac arrest care. Emerg Med Clin North Am. 2019; 37:381–93.
12. Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006; 69:199–206.